Evidence map›Paper›PMID 10097120›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

An exon that prevents transport of a mature mRNA.

M A MacMorris, D A Zorio, T Blumenthal

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Caspase-2 pre-mRNA alternative splicing: Identification of an intronic element containing a decoy 3' acceptor site.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M A MacMorrisDepartment of Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
D A Zorio
T Blumenthal
Indiana University Bloomington · USUniversity of Colorado Health · US

Funding

TRANS-SPLICING IN C ELEGANSR01GM042432 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BLUMENTHAL, THOMAS · 1992 to 2011
$3.9M
Trans-splicing in C. ElegansR56GM042432 · NIGMS · UNIVERSITY OF COLORADO · PI BLUMENTHAL, THOMAS · 2007 to 2007
$360k
NIGMS NIH HHS GM42432NIGMS NIH HHS R01 GM042432NIGMS NIH HHS R56 GM042432
6 · The paper itself

Abstract

In Caenorhabditis elegans, pre-mRNA for the essential splicing factor U2AF65 sometimes is spliced to produce an RNA that includes an extra 216-bp internal exon, exon 3. Inclusion of exon 3 inserts an in-frame stop codon, yet this RNA is not subject to SMG-mediated RNA surveillance. To test whether exon 3 causes RNA to remain nuclear and thereby escape decay, we inserted it into the 3' untranslated region of a gfp reporter gene. Although exon 3 did not affect accumulation or processing of the mRNA, it dramatically suppressed expression of green fluorescent protein (GFP). We showed by in situ hybridization that exon 3-containing gfp RNA is retained in the nucleus. Intriguingly, exon 3 contains 10 matches to the 8-bp 3' splice-site consensus. We hypothesized that U2AF might recognize this octamer and thereby prevent export. This idea is supported by RNA interference experiments in which reduced levels of U2AF resulted in a small burst of gfp expression.

Indexed as

ExonsNuclear ProteinsAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansGene Expression RegulationGreen Fluorescent ProteinsLuminescent ProteinsRecombinant ProteinsRibonucleoproteinsRNA, MessengerRNA SplicingSplicing Factor U2AFTranscription, GeneticGreen Fluorescent ProteinsLuminescent ProteinsNuclear ProteinsRecombinant ProteinsRibonucleoproteinsRNA, MessengerSplicing Factor U2AF

Identifiers

PMID10097120
PMCPMC22377
OpenAlexW1985008686

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.